Latest Breaking News On - Claudine isaacs - Page 2 : comparemela.com

Adjuvant Strategies in HER2+ Brest Cancer: Timing and Tailoring

Health care professionals review considerations in transitioning breast cancer patients to the adjuvant setting and discuss response monitoring, treatment tailoring, and the evolving role of imaging.

SABCS 2023 Findings Build on Positive Momentum in HER2+ Breast Cancer

Expert oncologists in the field of breast cancer review data in HER2-positive early-stage and metastatic breast cancer.

Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San Antonio Breast Cancer Symposium

Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San Antonio Breast Cancer Symposium

Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San Antonio Breast Cancer Symposium

Six abstracts have been accepted for presentation, including updated data on vepdegestrant alone and in combination with palbociclib NEW HAVEN, Conn. and NEW YORK, Nov. 28, 2023 .